Skip to content
DataLookout
Menu

NCT06377345

Remote Patient Monitoring Solution for Chronic Respiratory Disease Management

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 9 words Show 7 more changesShow less
    • Trial completed
    • Primary completion date changed from estimate of Sep 30, 2025 to Jan 30, 2026
    • Enrollment target: estimated 180 to confirmed 173
    • Study completion date changed from estimate of Dec 30, 2025 to Mar 30, 2026
    • Secondary endpoints: details revised at 6 of 8 entries
    • Study description expanded, about 9 words
    • Site details revised
  2. Notable Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Primary completion date: Dec 31, 2024 to Sep 30, 2025
    • Study sites: 0 to 1
    • Study completion date: Mar 30, 2025 to Dec 30, 2025
    • Start date changed from estimate of Apr 20, 2024 to May 1, 2024
  3. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Rescue therapy
Timeframe: up to 12 weeks
Dose of oral Prednisolone use
Timeframe: up to 12 weeks
Visit to hospital emergency department
Timeframe: up to 12 weeks
Hospitalisation
Timeframe: up to 12 weeks
Euro Quality of Life 5 dimensions (EQ5D)
Timeframe: up to 12 weeks (baseline, week 4, week, 12)
Asthma quality of life questionnaire (AQLQ)
Timeframe: up to 12 weeks (baseline, week 4, week, 12)
Pediatric asthma quality of life questionnaire (PAQLQ)
Timeframe: up to 12 weeks (baseline, week 4, week, 12)

Secondary (8)

Self-efficacy
Usability
Heart rate
Respiratory rate
Wheeze detection trend
Show 3 moreShow less
Medication log
Duration of device usage
Payment

Arms and interventions

Control groupActive comparator

The control group will receive the standard care provided by the Polyclinic. This can include a telephone follow-up by a nurse within 5 days, and follow-ups with a doctor after one week. All patients with asthma should also have an asthma action plan which provides them instructions on how to manage their asthma and the medications required when they experience symptoms. These symptoms include wheezing, chest tightness, difficulty breathing, coughing, night-waking, and symptom interfering with day-to-day activities.

Intervention groupExperimental

The intervention group will receive the AeviceMD device on top of standard care provided by the Polyclinic. They will use the AeviceMD device for 12 weeks. They are expected to use the device for at least 5 hours at night when they are asleep. However, they can also use the device at any time of the time, based on their own preference. The AeviceMD device will provide patients with objective information of their breathing (respiratory rate) and lung sounds. This objective information can be used for participants to self-manage their asthma following the asthma action plan. During the clinical follow-up, participants can show the clinician their lung parameters, to improve clinical management

Devices: AeviceMD device

Behavioral: Standard care

Sites

1 site in 1 country

  • SingHealth PolyclinicsSingapore, Singapore, Singapore